Nasdaq · Healthcare
908 Devices Inc. (MASS)
As-reported financials and recent SEC filings for 908 Devices Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$56.2M
Net income
$19.5M
Net margin
34.7%
Diluted EPS
$0.54
ROE
13.6%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $56.2M | $47.7M | $50.2M | $46.9M | $42.2M |
| Gross profit | $28.4M | $24.5M | $25.3M | $26.0M | $23.2M |
| Operating income | $-39.4M | $-57.4M | $-42.8M | $-35.4M | $-22.1M |
| Net income | $19.5M | $-72.2M | $-36.4M | $-33.6M | $-22.2M |
| Diluted EPS | $0.54 | $-2.12 | $-1.13 | $-1.07 | $-0.79 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-02
View on EDGAR →42026-06-30
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-24
View on EDGAR →1442026-06-23
View on EDGAR →42026-06-12
View on EDGAR →Largest Healthcare peers
Go deeper on MASS
Search 908 Devices Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.